These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 22338936)
1. Correlation between the circulating bone markers and vitamin D in the healthy Thai people. Buranasinsup S; Jangsangthong A; Bunyaratavej N J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S90-5. PubMed ID: 22338936 [TBL] [Abstract][Full Text] [Related]
2. Bone markers in the healthy Thai people. Buranasinsup S; Jangsangthong A; Bunyaratavej N J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S96-101. PubMed ID: 22338937 [TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916 [TBL] [Abstract][Full Text] [Related]
4. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317 [TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
6. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover. Schou AJ; Heuck C; Wolthers OD Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157 [TBL] [Abstract][Full Text] [Related]
8. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763 [TBL] [Abstract][Full Text] [Related]
9. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age. Lieuw-A-Fa M; Sierra RI; Specker BL J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307 [TBL] [Abstract][Full Text] [Related]
11. Study of validity of pyridinoline and correlation of pyridinoline and beta crosslap in postmenopausal women. Bunyaratavej N; Buranasinsup S J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S76-8. PubMed ID: 22338932 [TBL] [Abstract][Full Text] [Related]
12. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Tähtelä R; Thölix E Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558 [TBL] [Abstract][Full Text] [Related]
14. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265 [TBL] [Abstract][Full Text] [Related]
15. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction. Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953 [TBL] [Abstract][Full Text] [Related]
16. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254 [TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP]. Kobayashi Y; Ochi M; Tokue A Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802 [TBL] [Abstract][Full Text] [Related]
18. Osteoblastic functions: a lesson from biochemical bone markers. Bunyaratavej N J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S84-6. PubMed ID: 22338934 [TBL] [Abstract][Full Text] [Related]
19. A study of correlation of osteoblasts from peripheral blood with related bone turnover markers. Suriyachand K; Eamwijit T; Paisooksantivatana K; Hongeng S; Bunyaratavej N J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S71-5. PubMed ID: 22338931 [TBL] [Abstract][Full Text] [Related]
20. Type I collagen metabolites as tumor markers in patients with lung carcinoma. Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]